1. Home
  2. FNWB vs GNLX Comparison

FNWB vs GNLX Comparison

Compare FNWB & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo First Northwest Bancorp

FNWB

First Northwest Bancorp

N/A

Current Price

$9.97

Market Cap

98.5M

Sector

Finance

ML Signal

N/A

Logo Genelux Corporation

GNLX

Genelux Corporation

N/A

Current Price

$2.47

Market Cap

110.4M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FNWB
GNLX
Founded
1923
2001
Country
United States
United States
Employees
N/A
N/A
Industry
Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
98.5M
110.4M
IPO Year
2012
2022

Fundamental Metrics

Financial Performance
Metric
FNWB
GNLX
Price
$9.97
$2.47
Analyst Decision
Buy
Strong Buy
Analyst Count
2
6
Target Price
$15.00
★ $18.83
AVG Volume (30 Days)
26.0K
★ 211.2K
Earning Date
10-26-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 36.00
9.47
EPS
★ 0.04
N/A
Revenue
★ $176,000.00
$8,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$6.91
N/A
P/E Ratio
$250.75
★ N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$7.76
$2.29
52 Week High
$12.52
$8.54

Technical Indicators

Market Signals
Indicator
FNWB
GNLX
Relative Strength Index (RSI) 30.78 49.81
Support Level $9.88 $2.51
Resistance Level $10.38 $2.93
Average True Range (ATR) 0.28 0.12
MACD 0.00 0.01
Stochastic Oscillator 13.04 72.66

Price Performance

Historical Comparison
FNWB
GNLX

About FNWB First Northwest Bancorp

First Northwest Bancorp is a bank holding company and a financial holding company and is engaged in banking activities through its wholly owned subsidiary, First Fed Bank, as well as certain non-banking financial activities. It offers various products and services, such as commercial business loans, multi-family real estate loans, auto and consumer loans, transaction accounts, savings and money market accounts, online banking services, etc., focused on the lending, deposit, and money movement needs of individuals, businesses and nonprofit organizations. The Group's operations are mainly focused on serving various communities in Washington State, U.S. Substantially all of its income is derived from a diverse base of commercial, mortgage, and consumer lending activities and investments.

About GNLX Genelux Corporation

Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.

Share on Social Networks: